Developmental And Epileptic Encephalopathy 40

Mendelian MONDO:0014895 Pathograph 8 Show in embeddings browser Genetic Developmental and Epileptic Encephalopathy

DEE40 (EIEE40; OMIM 617065) is an autosomal recessive developmental and epileptic encephalopathy attributed to biallelic variants in GUF1, which encodes the nuclear genome-encoded mitochondrial translation elongation factor EF-4 (mtEF4), the eukaryotic homolog of bacterial LepA. The mechanism runs through mitochondrial protein synthesis rather than through an ion channel: mtEF4 is a fidelity factor that remobilizes stalled mitoribosomes and transiently inhibits elongation, and its disruption compromises assembly of the respiratory chain complexes whose core subunits are made inside the mitochondrion. The single reported family presented with isolated West syndrome — infantile spasms with hypsarrhythmia and developmental regression. The evidence base is deliberately small: one consanguineous family with three affected siblings (2016), a single additional GUF1 patient in a targeted gene-panel cohort (2023), and functional work in yeast, worm, and mouse rather than in human neural tissue. The final step from respiratory chain assembly failure to the epilepsy is proposed by the discovering authors and has not been measured in patients.

Ask OpenScientist

Ask a research question about Developmental And Epileptic Encephalopathy 40. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
4
Pathophys.
5
Phenotypes
2
Gaps
8
Pathograph
1
Genes
1
Medical Actions
3
Models
8
References
1
Deep Research
👪

Inheritance

1
Autosomal recessive inheritance HP:0000007
The reported family was consanguineous, and the three affected siblings were homozygous for the same GUF1 missense variant (c.1825G>T, p.(Ala609Ser)). Only one family has been reported with segregation data, so the recessive mode rests on that single pedigree together with Orphanet's gene-disease assertion.
Autosomal recessive inheritance
Show evidence (1 reference)
PMID:26486472 SUPPORT Human Clinical
"we exome-sequenced the members of a consanguineous family affected with isolated WS. We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."
Homozygosity for one variant in three affected siblings of a consanguineous family is the segregation pattern that establishes recessive inheritance here.
?

Discussions and Knowledge Gaps

2
Do DEE40 patients actually have a measurable respiratory chain or bioenergetic deficit, and is it present in neural tissue?
KNOWLEDGE GAP OPEN gap_human_neuronal_bioenergetics
Every respiratory chain observation supporting this entry comes from yeast, worm, or cultured human cancer cells. No muscle or fibroblast respiratory chain enzymology, lactate, or oxidative phosphorylation measurement has been published for a GUF1 patient, and the discovering authors present the link to West syndrome as a suggestion. Until such a measurement exists, the central effector node of this entry is supported only by cross-species inference, which is also why no conformance to a mitochondrial mechanism module is declared (see notes).
Proposed experiments
Respiratory chain assessment in GUF1 patient-derived cells
exp_guf1_patient_respiratory_chain
Measure respiratory chain complex activities, assembly by blue-native electrophoresis, and mitochondrial translation rates in fibroblasts or iPSC-derived neurons from a GUF1 p.(Ala609Ser) homozygote against controls, to establish whether the assembly defect seen in model systems is present in patient cells and whether it is neuron-selective.
Show evidence (1 reference)
PMID:26486472 SUPPORT INDIRECT Human Clinical
"We suggest a new link between improper assembly of respiratory chain complexes and WS."
The authors' own framing of the mechanism as a suggestion is what this gap records. Classified INDIRECT because it evidences the state of the argument rather than a measurement.
Why does mtEF4 knockout in the mouse produce testis-restricted disease while the human variant produces an epileptic encephalopathy with no reported fertility phenotype?
HUMAN MODEL MISMATCH OPEN gap_mouse_spares_nervous_system
This is a mismatch rather than an absence of evidence: the mouse knockout was made and characterised, and its phenotype is male infertility from testis-specific oxidative phosphorylation failure, with somatic tissues compensating through mTOR-driven cytoplasmic translation. The organ affected in the mouse is not the organ affected in the reported human family. Either the developing human brain cannot mount the somatic compensation that mouse somatic tissues can, or the human missense allele acts differently from a null, or the mouse neurological phenotype was simply not looked for. The distinction matters because the mouse is currently the only mammalian in vivo system available for this gene, and reading it as a model of DEE40 would misstate what has been shown.
Proposed experiments
Neurological phenotyping of mtEF4-deficient mice
exp_neuro_phenotyping_mtef4_mouse
Perform EEG, seizure-susceptibility and developmental assessment in constitutive and neuron-specific mtEF4 knockout mice, and measure mTOR pathway activity and cytoplasmic translation rates in brain, to test whether the nervous system is genuinely spared or merely unexamined, and whether neuronal compensation differs from that in other somatic tissues.
Knock-in of the patient allele
exp_knockin_a609s_mouse
Generate a mouse carrying the orthologous p.(Ala609Ser) substitution rather than a null allele, to test whether the human missense variant produces a neurological phenotype that complete ablation does not.
Show evidence (1 reference)
PMID:27065197 SUPPORT Model Organism
"Here we report that genetic ablation of mitochondrial EF4 (mtEF4) in mice causes testis-specific dysfunction in oxidative phosphorylation, leading to male infertility."
Documents the tissue specificity of the mouse phenotype, which is the mismatch with the human presentation that this discussion records.
⚙

Pathophysiology

4
Biallelic GUF1 Variants
The initiating lesion is a homozygous GUF1 missense variant. In the reported family the allele is c.1825G>T, p.(Ala609Ser), which substitutes an alanine conserved across all eukaryotic organisms and positioned within the tRNA-binding moiety of the protein. Note that the functional consequence is reported as a modification of activity under suboptimal conditions rather than as a clean null, so this node is deliberately not labelled a loss of function.
GUF1 hgnc:25799 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves GUF1 (hgnc:25799). hgnc:25799 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (1 reference)
PMID:26486472 SUPPORT Human Clinical
"The variant identified in the WS family changes an alanine residue conserved in all eukaryotic organisms and positioned within the tRNA-binding moiety of this nuclear genome-encoded mitochondrial translational elongation factor."
Locates the disease allele within the tRNA-binding region of mtEF4 and establishes the residue's conservation, the basis for treating it as the initiating lesion.
Impaired Mitochondrial Translation Elongation Fidelity
GUF1/mtEF4 is a quality-control factor of mitochondrial protein synthesis rather than a core elongation engine: it binds mitoribosomes in a GTP-dependent manner, remobilizes stalled ribosomes, and transiently inhibits elongation so that synthesis remains accurate. No modifier is asserted on the elongation process below because the reported direction is condition-dependent — yeast lacking Guf1 show diminished synthesis rates at low temperature, whereas mouse mtEF4 deletion accelerates mitochondrial translation at the cost of producing unstable proteins. What is consistent across systems is the loss of fidelity, not a single direction of rate change.
mitochondrial translational elongation GO:0070125 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves mitochondrial translational elongation (GO:0070125). GO:0070125 is a biological process from the Gene Ontology.
GTPase activity GO:0003924 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves GTPase activity (GO:0003924). GO:0003924 is a molecular function from the Gene Ontology.
Show evidence (4 references)
PMID:26486472 SUPPORT Other
"GUF1 encodes a protein essential in conditions that counteract faithful protein synthesis: it is able to remobilize stuck ribosomes and transiently inhibit the elongation process to optimize protein synthesis."
States the molecular role of the gene product that this node models. Evidence source is OTHER because the sentence is background molecular biology synthesised from model-system work, not a clinical observation made in this study.
PMID:18442968 SUPPORT In Vitro
"The observed defects in Guf1-deficient mitochondria are consistent with a function of Guf1 as a fidelity factor of mitochondrial protein synthesis."
Establishes the fidelity-factor role in the yeast ortholog, the conserved function whose disruption this node describes.
PMID:18442968 SUPPORT In Vitro
"It binds to mitochondrial ribosomes in a GTP-dependent manner."
Supports the GTPase and ribosome-engagement molecular function annotated on this node.
+ 1 more reference
Defective Respiratory Chain Complex Assembly
Loss of mtEF4 function impairs biogenesis of the oxidative phosphorylation complexes, with complex IV the most consistently affected across model systems: cytochrome oxidase assembly fails in Guf1-deficient yeast at restrictive temperature, respiratory chain supercomplexes containing complex IV are disrupted in mtef4-null C. elegans at low temperature, and knockout of mtEF4 in human cells induces respiratory chain complex defects and apoptosis. This node is the mechanistic pivot the discovering authors proposed for the epilepsy, and it is supported entirely by non-human or non-neural systems — no respiratory chain measurement has been reported in a DEE40 patient.
mitochondrial respiratory chain complex assembly GO:0033108 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased mitochondrial respiratory chain complex assembly (GO:0033108). GO:0033108 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (3 references)
PMID:24837196 SUPPORT Model Organism
"At low temperature (15°C), mtef4 deletion reduces mitochondrial translation and disrupts the assembly of respiratory chain supercomplexes containing complex IV."
A whole-organism metazoan result tying mtEF4 loss to disrupted complex IV supercomplex assembly.
PMID:29572227 SUPPORT In Vitro
"Knockout of mtEF4 induced respiratory chain complex defects and apoptosis, while its overexpression stimulated cancer development."
Shows the same consequence for the human protein in cultured cells. Cited only for the respiratory chain phenotype of mtEF4 loss; the tumour biology that is this paper's subject is not relevant to DEE40.
PMID:30693836 SUPPORT Other
"We will discuss the influence of mtEF4 on the electron transport chain, especially at respiratory chain complex IV, which could result in cytochrome c peroxidase formation, electron leakage from electron transport chain and ROS increase."
A review summarising the complex IV focus of the mtEF4 respiratory phenotype and the proposed ROS consequence. Evidence source is OTHER because this is a review, and the ROS arm is stated as a possibility ("could result in"), so it is not asserted as a node here.
Neuronal Energy Failure and Epileptic Encephalopathy
The clinical endpoint is an early-infantile developmental and epileptic encephalopathy presenting as West syndrome. The energy-failure framing is inherited from the general association between respiratory chain disorders and infantile epilepsy rather than from any measurement in GUF1 patients, which is why this node carries no biological process annotation asserting a bioenergetic deficit in human neural tissue.
Show evidence (1 reference)
PMID:26486472 SUPPORT Human Clinical
"To get better insights on the genetic of this pathology, we exome-sequenced the members of a consanguineous family affected with isolated WS."
Establishes that the affected siblings' clinical endpoint was isolated West syndrome, the phenotype this consequence node represents.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Developmental And Epileptic Encephalopathy 40 Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

5
Metabolism 1
Refractory epilepsy Refractory drug response HP:0020174 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Refractory epilepsy, annotated with Refractory drug response (HP:0020174). HP:0020174 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:37820178 SUPPORT INDIRECT Human Clinical
"Targeted next-generation sequencing molecular genetics results were reviewed, and 3 ALDH7A1, 1 AARS, 3 CACNA1A, 1 CTNNB1, 1 DCX, 2 DBH, 2 DOCK7, 1 FOLR1, 2 GABRB3, 2 GCH1, 1 VGRIN2B, 1 GUF1, 3 KCNQ2, 2 KCNT1, 1 NECAP1, 1 PCDH19, 1 PNPO, 1 SCN8A, 1 SCN9A, 4 SCN1A, 2 SLC25A22, 1 SLC2A1, 2 SPTAN1,..."
Classified INDIRECT: documents that a GUF1 patient was among those genotyped in a cohort defined by refractory epilepsy, establishing the drug-resistance by enrolment criterion rather than by individual report.
Nervous System 4
Infantile spasms HP:0012469 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Infantile spasms (HP:0012469). HP:0012469 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:26486472 SUPPORT INDIRECT Human Clinical
"West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."
Classified INDIRECT: the paper states the siblings had isolated West syndrome and separately defines that syndrome by this triad, so the spasms follow from the diagnosis rather than from a per-patient description. The accessible record for this paper does not include the case narratives.
ORPHA:697160 SUPPORT Other
"GUF1 | GTP binding elongation factor GUF1 | hgnc:25799 | Disease-causing germline mutation(s) in"
Orphanet's gene-disease row placing GUF1 among the causes of infantile epileptic spasms syndrome, independent of the primary report.
Hypsarrhythmia HP:0002521 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypsarrhythmia (HP:0002521). HP:0002521 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:26486472 SUPPORT INDIRECT Human Clinical
"West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."
Classified INDIRECT for the same reason as the spasms phenotype: the EEG pattern follows from the stated West syndrome diagnosis rather than from a reported per-patient EEG in the accessible record.
Developmental regression HP:0002376 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Developmental regression (HP:0002376), qualified as course progressive. HP:0002376 is a phenotype from the Human Phenotype Ontology.
Course: PROGRESSIVE
Show evidence (1 reference)
PMID:26486472 SUPPORT INDIRECT Human Clinical
"West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."
Classified INDIRECT: regression follows from the West syndrome diagnosis applied to these siblings rather than from an individual case description.
Global developmental delay HP:0001263 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Global developmental delay (HP:0001263). HP:0001263 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:37820178 SUPPORT INDIRECT Human Clinical
"In this retrospective cohort study, patients with refractory epilepsy and global developmental delay, defined as epileptic encephalopathy, who applied to the Aydın 7Maternity and Children's Hospital Genetic Diagnosis Center and were followed in the pediatric neurology clinic of our hospital,..."
Classified INDIRECT: this is the cohort inclusion criterion, and a GUF1 patient was among those enrolled, so the delay is inferred from cohort membership rather than reported individually.
🧬

Genetic Associations

1
GUF1 (Pathogenic Variants)
Gene: GUF1 hgnc:25799 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is GUF1 (hgnc:25799). hgnc:25799 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (3 references)
PMID:26486472 SUPPORT Human Clinical
"We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."
The variant-level gene-disease observation on which the entry rests.
ORPHA:697160 SUPPORT Other
"GUF1 | GTP binding elongation factor GUF1 | hgnc:25799 | Disease-causing germline mutation(s) in"
Orphanet's curated gene-disease assertion for GUF1, corroborating the causative relationship recorded here.
PMID:37820178 SUPPORT Human Clinical
"An identifiable underlying genetic cause was identified in 48 (25%) out of 198 patients."
Establishes the diagnostic-yield context of the panel cohort in which one further GUF1 patient was identified.
💊

Medical Actions

1
Genetic counseling
Action: genetic counselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is genetic counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. Ontology label: Genetic Counseling NCIT:C15240
Because DEE40 is autosomal recessive and the reported family was consanguineous, recurrence-risk counselling and carrier testing are part of family care. No disease-modifying or GUF1-specific therapy exists, and no antiseizure drug response has been reported in a GUF1 patient (see notes).
Show evidence (1 reference)
PMID:26486472 SUPPORT Human Clinical
"we exome-sequenced the members of a consanguineous family affected with isolated WS. We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."
Establishes the consanguineous, biallelic recurrence situation that makes recurrence-risk counselling relevant.
🔬

Diagnosis

4
Electroencephalography
EEG demonstrating hypsarrhythmia is what establishes the West syndrome presentation through which DEE40 has come to clinical attention; the pattern is pathognomonic for the syndrome. Etiologic diagnosis then requires sequencing.
electroencephalography NCIT:C38054 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:26486472 SUPPORT INDIRECT Human Clinical
"West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."
The paper calls hypsarrhythmia pathognomonic of the syndrome the siblings carried, and hypsarrhythmia is an EEG finding, which is what makes EEG the presentation-defining test. Classified INDIRECT because the sentence is definitional rather than a report of the patients' own EEG recordings.
Brain magnetic resonance imaging
Cranial imaging is performed to exclude a structural cause for the seizures rather than to identify a DEE40-specific lesion. In the panel cohort that ascertained a GUF1 patient, imaging was done in every patient and found no structural anomaly capable of causing the seizures — an exclusionary result. No DEE40-specific neuroimaging finding has been described.
brain magnetic resonance imaging NCIT:C16809 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:37820178 SUPPORT INDIRECT Human Clinical
"Cranial imaging was performed in all patients. There was no structural anomaly that could cause a seizure."
Establishes imaging as a routine exclusionary step in the cohort that included a GUF1 patient. Classified INDIRECT because the finding is reported for the whole 198-patient cohort rather than for the GUF1 patient individually.
Whole exome sequencing
GUF1 was identified as the candidate gene by exome sequencing of a consanguineous multiplex family, and exome or genome sequencing remains the route to a DEE40 diagnosis.
whole exome sequencing NCIT:C101295 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:26486472 SUPPORT Human Clinical
"we exome-sequenced the members of a consanguineous family affected with isolated WS"
Establishes exome sequencing as the method that produced the diagnosis.
Targeted next-generation sequencing epilepsy panel
GUF1 is included on targeted epilepsy gene panels, which is how the one further reported patient was ascertained.
targeted next-generation sequencing gene panel NCIT:C198412 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:37820178 SUPPORT Human Clinical
"Targeted next-generation sequencing molecular genetics results were reviewed"
Documents the targeted panel as the diagnostic modality in the cohort that identified a GUF1 patient.
📊

Prevalence

1
Worldwide
Cases In Literature Ultra Rare
DEE40 is ultra-rare and has no estimated population prevalence. The reported literature amounts to three affected siblings in one consanguineous family (2016) and one further patient carrying a GUF1 variant in a 198-patient targeted next-generation sequencing cohort (2023) — four patients in total by that count, which is a dated lower bound rather than a current total. The 1:3500 figure quoted in the primary report is the birth incidence of West syndrome from all causes, not of GUF1-related disease, and must not be read as a DEE40 rate.
Show evidence (1 reference)
PMID:26486472 SUPPORT Human Clinical
"We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."
The three-sibling count from the index family, kept as a literature case count rather than converted to a population rate.
🧫

Experimental Models

1
Yeast guf1-null complementation assay OTHER
Saccharomyces cerevisiae lacking GUF1 has cold- and heat-sensitive growth defects on non-fermentable carbon sources and defective cytochrome oxidase assembly. Complementing that strain with human GUF1 alleles grades their function, and this is the assay that supplied the only functional evidence for the patient variant.
Organism
Saccharomyces cerevisiae NCBITaxon:4932 NCBI Taxonomy (NCBITaxon) Relation: this experimental model is built in this organism This experimental model is built in Saccharomyces cerevisiae (NCBITaxon:4932). NCBITaxon:4932 is an organism from the NCBI Taxonomy.
Publication
Show evidence (1 reference)
PMID:18442968 SUPPORT In Vitro
"Mutants lacking Guf1 show cold- and heat-sensitive growth defects on non-fermentable carbon sources that are especially pronounced under nutrient-limiting conditions."
Characterises the yeast null phenotype that makes the complementation readout interpretable.
🐁

Animal Models

2
mtEF4 knockout mouse Genetic
Whole-animal and germline-specific mtEF4 knockout mice were made to test the physiological requirement for the factor. The result is informative for the translation node of this entry and, equally importantly, is a negative result for the neurological one: the phenotype is testis-restricted male infertility, with somatic tissues compensating through mTOR-driven cytoplasmic translation. No epilepsy or encephalopathy phenotype is reported.
Species
Mouse
Genotype
mtEF4 (Guf1) knockout, including germline-specific conditional deletion
Publication
mtef4-null Caenorhabditis elegans Genetic
Deleting the C. elegans mtEF4 ortholog produces mitochondrial dysfunction, growth delay and reduced brood size at normal temperature, and at low temperature reduces mitochondrial translation and disrupts complex IV-containing respiratory chain supercomplexes. It is the model that connects the translation defect to respiratory chain assembly in a whole metazoan.
Species
Caenorhabditis elegans
Genotype
mtef4 (C. elegans mtEF4 ortholog) deletion
Publication
Show evidence (1 reference)
PMID:24837196 SUPPORT Model Organism
"At worms' optimum growing temperature (20°C), mtef4 deletion leads to self-brood size reduction, growth delay and mitochondrial dysfunction."
Establishes that the deletion causes mitochondrial dysfunction in this organism even without cold stress.
{ }

Source YAML

click to show
name: Developmental And Epileptic Encephalopathy 40
creation_date: "2026-09-05T19:12:28Z"
description: >-
  DEE40 (EIEE40; OMIM 617065) is an autosomal recessive developmental and
  epileptic encephalopathy attributed to biallelic variants in GUF1, which
  encodes the nuclear genome-encoded mitochondrial translation elongation factor
  EF-4 (mtEF4), the eukaryotic homolog of bacterial LepA. The mechanism runs
  through mitochondrial protein synthesis rather than through an ion channel:
  mtEF4 is a fidelity factor that remobilizes stalled mitoribosomes and
  transiently inhibits elongation, and its disruption compromises assembly of
  the respiratory chain complexes whose core subunits are made inside the
  mitochondrion. The single reported family presented with isolated West
  syndrome — infantile spasms with hypsarrhythmia and developmental regression.
  The evidence base is deliberately small: one consanguineous family with three
  affected siblings (2016), a single additional GUF1 patient in a targeted
  gene-panel cohort (2023), and functional work in yeast, worm, and mouse rather
  than in human neural tissue. The final step from respiratory chain assembly
  failure to the epilepsy is proposed by the discovering authors and has not
  been measured in patients.
category: Mendelian
parents:
- Genetic Developmental and Epileptic Encephalopathy
synonyms:
- DEE40
- EIEE40
- early infantile epileptic encephalopathy 40
- epileptic encephalopathy, early infantile, 40
- GUF1 early infantile epileptic encephalopathy
- early infantile epileptic encephalopathy caused by mutation in GUF1
disease_term:
  preferred_term: developmental and epileptic encephalopathy, 40
  term:
    id: MONDO:0014895
    label: developmental and epileptic encephalopathy, 40
inheritance:
- name: Autosomal recessive inheritance
  description: >-
    The reported family was consanguineous, and the three affected siblings were
    homozygous for the same GUF1 missense variant (c.1825G>T, p.(Ala609Ser)).
    Only one family has been reported with segregation data, so the recessive
    mode rests on that single pedigree together with Orphanet's gene-disease
    assertion.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:26486472
    reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we exome-sequenced the members of a consanguineous family affected with isolated WS. We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."
    explanation: >-
      Homozygosity for one variant in three affected siblings of a consanguineous
      family is the segregation pattern that establishes recessive inheritance
      here.
pathophysiology:
- name: Biallelic GUF1 Variants
  biological_scale: MOLECULAR
  role: trigger
  description: >-
    The initiating lesion is a homozygous GUF1 missense variant. In the reported
    family the allele is c.1825G>T, p.(Ala609Ser), which substitutes an alanine
    conserved across all eukaryotic organisms and positioned within the
    tRNA-binding moiety of the protein. Note that the functional consequence is
    reported as a modification of activity under suboptimal conditions rather
    than as a clean null, so this node is deliberately not labelled a loss of
    function.
  genes:
  - preferred_term: GUF1
    term:
      id: hgnc:25799
      label: GUF1
  evidence:
  - reference: PMID:26486472
    reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The variant identified in the WS family changes an alanine residue conserved in all eukaryotic organisms and positioned within the tRNA-binding moiety of this nuclear genome-encoded mitochondrial translational elongation factor."
    explanation: >-
      Locates the disease allele within the tRNA-binding region of mtEF4 and
      establishes the residue's conservation, the basis for treating it as the
      initiating lesion.
  downstream:
  - target: Impaired Mitochondrial Translation Elongation Fidelity
    causal_link_type: DIRECT
    description: >-
      The variant alters mtEF4 activity in the conditions under which the factor
      is required, as measured by yeast complementation.
    evidence:
    - reference: PMID:26486472
      reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Yeast complementation assays show that the activity of GUF1(A609S) is modified in suboptimal environments."
      explanation: >-
        The functional assay linking the patient allele to altered elongation
        factor activity, which is the next node.
- name: Impaired Mitochondrial Translation Elongation Fidelity
  biological_scale: MOLECULAR
  description: >-
    GUF1/mtEF4 is a quality-control factor of mitochondrial protein synthesis
    rather than a core elongation engine: it binds mitoribosomes in a
    GTP-dependent manner, remobilizes stalled ribosomes, and transiently inhibits
    elongation so that synthesis remains accurate. No modifier is asserted on the
    elongation process below because the reported direction is
    condition-dependent — yeast lacking Guf1 show diminished synthesis rates at
    low temperature, whereas mouse mtEF4 deletion accelerates mitochondrial
    translation at the cost of producing unstable proteins. What is consistent
    across systems is the loss of fidelity, not a single direction of rate
    change.
  biological_processes:
  - preferred_term: mitochondrial translational elongation
    term:
      id: GO:0070125
      label: mitochondrial translational elongation
  molecular_functions:
  - preferred_term: GTPase activity
    term:
      id: GO:0003924
      label: GTPase activity
  evidence:
  - reference: PMID:26486472
    reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "GUF1 encodes a protein essential in conditions that counteract faithful protein synthesis: it is able to remobilize stuck ribosomes and transiently inhibit the elongation process to optimize protein synthesis."
    explanation: >-
      States the molecular role of the gene product that this node models.
      Evidence source is OTHER because the sentence is background molecular
      biology synthesised from model-system work, not a clinical observation
      made in this study.
  - reference: PMID:18442968
    reference_title: The membrane-bound GTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The observed defects in Guf1-deficient mitochondria are consistent with a function of Guf1 as a fidelity factor of mitochondrial protein synthesis."
    explanation: >-
      Establishes the fidelity-factor role in the yeast ortholog, the conserved
      function whose disruption this node describes.
  - reference: PMID:18442968
    reference_title: The membrane-bound GTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "It binds to mitochondrial ribosomes in a GTP-dependent manner."
    explanation: >-
      Supports the GTPase and ribosome-engagement molecular function annotated on
      this node.
  - reference: PMID:27065197
    reference_title: Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Deletion of mtEF4 accelerated mitochondrial translation at the cost of producing unstable proteins."
    explanation: >-
      The mammalian in vivo result, and the reason this node asserts a fidelity
      defect without asserting a direction of rate change: here loss of mtEF4
      speeds translation up rather than slowing it.
  downstream:
  - target: Defective Respiratory Chain Complex Assembly
    causal_link_type: DIRECT
    description: >-
      Because the mitochondrially translated polypeptides are the core subunits
      of the respiratory chain complexes, infidelity in their synthesis yields
      products that cannot be assembled into functional complexes.
    evidence:
    - reference: PMID:18442968
      reference_title: The membrane-bound GTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "At elevated temperatures, Guf1-deficient mutants exhibit defects in the assembly of cytochrome oxidase, suggesting that the polypeptides produced are not functional."
      explanation: >-
        Directly connects the translation-fidelity defect to failed cytochrome
        oxidase assembly, which is the causal step this edge asserts.
- name: Defective Respiratory Chain Complex Assembly
  biological_scale: CELLULAR
  role: central_effector
  description: >-
    Loss of mtEF4 function impairs biogenesis of the oxidative phosphorylation
    complexes, with complex IV the most consistently affected across model
    systems: cytochrome oxidase assembly fails in Guf1-deficient yeast at
    restrictive temperature, respiratory chain supercomplexes containing complex
    IV are disrupted in mtef4-null C. elegans at low temperature, and knockout of
    mtEF4 in human cells induces respiratory chain complex defects and apoptosis.
    This node is the mechanistic pivot the discovering authors proposed for the
    epilepsy, and it is supported entirely by non-human or non-neural systems —
    no respiratory chain measurement has been reported in a DEE40 patient.
  biological_processes:
  - preferred_term: mitochondrial respiratory chain complex assembly
    term:
      id: GO:0033108
      label: mitochondrial respiratory chain complex assembly
    modifier: DECREASED
  evidence:
  - reference: PMID:24837196
    reference_title: Mitochondrial EF4 links respiratory dysfunction and cytoplasmic translation in Caenorhabditis elegans.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "At low temperature (15°C), mtef4 deletion reduces mitochondrial translation and disrupts the assembly of respiratory chain supercomplexes containing complex IV."
    explanation: >-
      A whole-organism metazoan result tying mtEF4 loss to disrupted complex IV
      supercomplex assembly.
  - reference: PMID:29572227
    reference_title: Human Elongation Factor 4 Regulates Cancer Bioenergetics by Acting as a Mitochondrial Translation Switch.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Knockout of mtEF4 induced respiratory chain complex defects and apoptosis, while its overexpression stimulated cancer development."
    explanation: >-
      Shows the same consequence for the human protein in cultured cells. Cited
      only for the respiratory chain phenotype of mtEF4 loss; the tumour biology
      that is this paper's subject is not relevant to DEE40.
  - reference: PMID:30693836
    reference_title: Mitochondrial translation factor EF4 regulates oxidative phosphorylation complexes and the production of ROS.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "We will discuss the influence of mtEF4 on the electron transport chain, especially at respiratory chain complex IV, which could result in cytochrome c peroxidase formation, electron leakage from electron transport chain and ROS increase."
    explanation: >-
      A review summarising the complex IV focus of the mtEF4 respiratory
      phenotype and the proposed ROS consequence. Evidence source is OTHER
      because this is a review, and the ROS arm is stated as a possibility
      ("could result in"), so it is not asserted as a node here.
  downstream:
  - target: Neuronal Energy Failure and Epileptic Encephalopathy
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The step from respiratory chain assembly failure to infantile spasms is the
      link the discovering authors proposed, by analogy with the broader
      association between respiratory chain defects and infantile epilepsy. The
      intervening events in developing human neurons have not been demonstrated.
    evidence:
    - reference: PMID:26486472
      reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: "We suggest a new link between improper assembly of respiratory chain complexes and WS."
      explanation: >-
        Classified INDIRECT because the authors offer this as a suggested link
        rather than a demonstrated mechanism; no patient respiratory chain or
        neuronal measurement is reported.
- name: Neuronal Energy Failure and Epileptic Encephalopathy
  biological_scale: ORGANISM
  role: consequence
  description: >-
    The clinical endpoint is an early-infantile developmental and epileptic
    encephalopathy presenting as West syndrome. The energy-failure framing is
    inherited from the general association between respiratory chain disorders
    and infantile epilepsy rather than from any measurement in GUF1 patients,
    which is why this node carries no biological process annotation asserting a
    bioenergetic deficit in human neural tissue.
  evidence:
  - reference: PMID:26486472
    reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To get better insights on the genetic of this pathology, we exome-sequenced the members of a consanguineous family affected with isolated WS."
    explanation: >-
      Establishes that the affected siblings' clinical endpoint was isolated West
      syndrome, the phenotype this consequence node represents.
phenotypes:
- name: Infantile spasms
  category: Neurologic
  description: >-
    The reported siblings had isolated West syndrome, of which infantile spasms
    are the defining seizure type. Orphanet independently lists GUF1 as a
    disease-causing gene for infantile epileptic spasms syndrome.
  phenotype_term:
    preferred_term: Infantile spasms
    term:
      id: HP:0012469
      label: Infantile spasms
  evidence:
  - reference: PMID:26486472
    reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."
    explanation: >-
      Classified INDIRECT: the paper states the siblings had isolated West
      syndrome and separately defines that syndrome by this triad, so the spasms
      follow from the diagnosis rather than from a per-patient description. The
      accessible record for this paper does not include the case narratives.
  - reference: ORPHA:697160
    reference_title: Infantile epileptic spasms syndrome
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "GUF1 | GTP binding elongation factor GUF1 | hgnc:25799 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet's gene-disease row placing GUF1 among the causes of infantile
      epileptic spasms syndrome, independent of the primary report.
- name: Hypsarrhythmia
  category: Neurologic
  description: >-
    Hypsarrhythmia is the pathognomonic interictal EEG pattern of West syndrome,
    the diagnosis carried by the reported siblings.
  phenotype_term:
    preferred_term: Hypsarrhythmia
    term:
      id: HP:0002521
      label: Hypsarrhythmia
  evidence:
  - reference: PMID:26486472
    reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."
    explanation: >-
      Classified INDIRECT for the same reason as the spasms phenotype: the EEG
      pattern follows from the stated West syndrome diagnosis rather than from a
      reported per-patient EEG in the accessible record.
- name: Developmental regression
  category: Neurologic
  description: >-
    Loss of acquired developmental skills is the third element of the West
    syndrome triad by which the affected siblings were characterised.
  phenotype_term:
    preferred_term: Developmental regression
    term:
      id: HP:0002376
      label: Developmental regression
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:26486472
    reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."
    explanation: >-
      Classified INDIRECT: regression follows from the West syndrome diagnosis
      applied to these siblings rather than from an individual case description.
- name: Global developmental delay
  category: Neurologic
  description: >-
    A further GUF1 patient was ascertained in a paediatric cohort whose entry
    criterion was refractory epilepsy together with global developmental delay.
    The delay is therefore established for that patient by cohort membership.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:37820178
    reference_title: Importance of targeted next-generation sequencing in pediatric patients with developmental epileptic encephalopathy.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "In this retrospective cohort study, patients with refractory epilepsy and global developmental delay, defined as epileptic encephalopathy, who applied to the Aydın 7Maternity and Children's Hospital Genetic Diagnosis Center and were followed in the pediatric neurology clinic of our hospital, between July 2018 and July 2021, were included."
    explanation: >-
      Classified INDIRECT: this is the cohort inclusion criterion, and a GUF1
      patient was among those enrolled, so the delay is inferred from cohort
      membership rather than reported individually.
- name: Refractory epilepsy
  category: Neurologic
  description: >-
    The same cohort required drug-resistant epilepsy for enrolment, so the
    reported GUF1 patient's epilepsy was refractory.
  phenotype_term:
    preferred_term: Refractory epilepsy
    term:
      id: HP:0020174
      label: Refractory drug response
  evidence:
  - reference: PMID:37820178
    reference_title: Importance of targeted next-generation sequencing in pediatric patients with developmental epileptic encephalopathy.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Targeted next-generation sequencing molecular genetics results were reviewed, and 3 ALDH7A1, 1 AARS, 3 CACNA1A, 1 CTNNB1, 1 DCX, 2 DBH, 2 DOCK7, 1 FOLR1, 2 GABRB3, 2 GCH1, 1 VGRIN2B, 1 GUF1, 3 KCNQ2, 2 KCNT1, 1 NECAP1, 1 PCDH19, 1 PNPO, 1 SCN8A, 1 SCN9A, 4 SCN1A, 2 SLC25A22, 1 SLC2A1, 2 SPTAN1, 2 SZT2, 4 TBC1D24, 2 TH, and 1 PCDH19 (X chromosome) mutations were detected in three of the patients using the next-generation sequencing method."
    explanation: >-
      Classified INDIRECT: documents that a GUF1 patient was among those
      genotyped in a cohort defined by refractory epilepsy, establishing the
      drug-resistance by enrolment criterion rather than by individual report.
genetic:
- name: GUF1
  gene_term:
    preferred_term: GUF1
    term:
      id: hgnc:25799
      label: GUF1
  association: Pathogenic Variants
  relationship_type: CAUSATIVE
  notes: >-
    GUF1 (GTP binding elongation factor GUF1) is the only gene implicated in
    DEE40 (MONDO:0014895; OMIM 617065). The single reported segregating allele is
    the homozygous missense c.1825G>T, p.(Ala609Ser), found in three affected
    siblings of one consanguineous family by exome sequencing. A second,
    unspecified GUF1 variant was reported in one patient of a 198-patient
    targeted-panel cohort. The gene-disease relationship therefore rests on a
    single multiplex pedigree plus a supportive functional assay, and Orphanet
    lists GUF1 among the disease-causing genes for infantile epileptic spasms
    syndrome. External gene-disease validity curation reflects the same thin
    base: Genomics England PanelApp lists GUF1 at AMBER (confidence level 2) on
    its early onset or syndromic epilepsy panel, and at RED (level 1) on its
    mitochondrial disorders panel (PanelApp API, checked 2026-09-06; recorded as
    prose because PanelApp is not a snippet-citable structured source in this
    repository). No functional_impact_category is asserted: the yeast assay
    reports that the variant's activity is "modified in suboptimal environments"
    rather than abolished, which does not license a loss-of-function call.
  evidence:
  - reference: PMID:26486472
    reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."
    explanation: >-
      The variant-level gene-disease observation on which the entry rests.
  - reference: ORPHA:697160
    reference_title: Infantile epileptic spasms syndrome
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "GUF1 | GTP binding elongation factor GUF1 | hgnc:25799 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet's curated gene-disease assertion for GUF1, corroborating the
      causative relationship recorded here.
  - reference: PMID:37820178
    reference_title: Importance of targeted next-generation sequencing in pediatric patients with developmental epileptic encephalopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "An identifiable underlying genetic cause was identified in 48 (25%) out of 198 patients."
    explanation: >-
      Establishes the diagnostic-yield context of the panel cohort in which one
      further GUF1 patient was identified.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    DEE40 is ultra-rare and has no estimated population prevalence. The reported
    literature amounts to three affected siblings in one consanguineous family
    (2016) and one further patient carrying a GUF1 variant in a 198-patient
    targeted next-generation sequencing cohort (2023) — four patients in total by
    that count, which is a dated lower bound rather than a current total. The
    1:3500 figure quoted in the primary report is the birth incidence of West
    syndrome from all causes, not of GUF1-related disease, and must not be read
    as a DEE40 rate.
  evidence:
  - reference: PMID:26486472
    reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."
    explanation: >-
      The three-sibling count from the index family, kept as a literature case
      count rather than converted to a population rate.
diagnosis:
- name: Electroencephalography
  description: >-
    EEG demonstrating hypsarrhythmia is what establishes the West syndrome
    presentation through which DEE40 has come to clinical attention; the pattern
    is pathognomonic for the syndrome. Etiologic diagnosis then requires
    sequencing.
  diagnosis_term:
    preferred_term: electroencephalography
    term:
      id: NCIT:C38054
      label: Electroencephalography
  evidence:
  - reference: PMID:26486472
    reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."
    explanation: >-
      The paper calls hypsarrhythmia pathognomonic of the syndrome the siblings
      carried, and hypsarrhythmia is an EEG finding, which is what makes EEG the
      presentation-defining test. Classified INDIRECT because the sentence is
      definitional rather than a report of the patients' own EEG recordings.
- name: Brain magnetic resonance imaging
  description: >-
    Cranial imaging is performed to exclude a structural cause for the seizures
    rather than to identify a DEE40-specific lesion. In the panel cohort that
    ascertained a GUF1 patient, imaging was done in every patient and found no
    structural anomaly capable of causing the seizures — an exclusionary result.
    No DEE40-specific neuroimaging finding has been described.
  diagnosis_term:
    preferred_term: brain magnetic resonance imaging
    term:
      id: NCIT:C16809
      label: Magnetic Resonance Imaging
  evidence:
  - reference: PMID:37820178
    reference_title: Importance of targeted next-generation sequencing in pediatric patients with developmental epileptic encephalopathy.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cranial imaging was performed in all patients. There was no structural anomaly that could cause a seizure."
    explanation: >-
      Establishes imaging as a routine exclusionary step in the cohort that
      included a GUF1 patient. Classified INDIRECT because the finding is
      reported for the whole 198-patient cohort rather than for the GUF1 patient
      individually.
- name: Whole exome sequencing
  description: >-
    GUF1 was identified as the candidate gene by exome sequencing of a
    consanguineous multiplex family, and exome or genome sequencing remains the
    route to a DEE40 diagnosis.
  diagnosis_term:
    preferred_term: whole exome sequencing
    term:
      id: NCIT:C101295
      label: Whole Exome Sequencing
  evidence:
  - reference: PMID:26486472
    reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we exome-sequenced the members of a consanguineous family affected with isolated WS"
    explanation: >-
      Establishes exome sequencing as the method that produced the diagnosis.
- name: Targeted next-generation sequencing epilepsy panel
  description: >-
    GUF1 is included on targeted epilepsy gene panels, which is how the one
    further reported patient was ascertained.
  diagnosis_term:
    preferred_term: targeted next-generation sequencing gene panel
    term:
      id: NCIT:C198412
      label: Multi-gene Panel Sequencing
  evidence:
  - reference: PMID:37820178
    reference_title: Importance of targeted next-generation sequencing in pediatric patients with developmental epileptic encephalopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Targeted next-generation sequencing molecular genetics results were reviewed"
    explanation: >-
      Documents the targeted panel as the diagnostic modality in the cohort that
      identified a GUF1 patient.
treatments:
- name: Genetic counseling
  description: >-
    Because DEE40 is autosomal recessive and the reported family was
    consanguineous, recurrence-risk counselling and carrier testing are part of
    family care. No disease-modifying or GUF1-specific therapy exists, and no
    antiseizure drug response has been reported in a GUF1 patient (see notes).
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:26486472
    reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we exome-sequenced the members of a consanguineous family affected with isolated WS. We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."
    explanation: >-
      Establishes the consanguineous, biallelic recurrence situation that makes
      recurrence-risk counselling relevant.
animal_models:
- name: mtEF4 knockout mouse
  species: Mouse
  genotype: mtEF4 (Guf1) knockout, including germline-specific conditional deletion
  category: Genetic
  publication: PMID:27065197
  description: >-
    Whole-animal and germline-specific mtEF4 knockout mice were made to test the
    physiological requirement for the factor. The result is informative for the
    translation node of this entry and, equally importantly, is a negative result
    for the neurological one: the phenotype is testis-restricted male infertility,
    with somatic tissues compensating through mTOR-driven cytoplasmic
    translation. No epilepsy or encephalopathy phenotype is reported.
  modeled_mechanisms:
  - target: Impaired Mitochondrial Translation Elongation Fidelity
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: ORGANISM
    description: >-
      Deleting mtEF4 in the mouse produces exactly the fidelity defect this node
      models — mitochondrial translation runs faster and yields unstable
      proteins — giving the node a mammalian in vivo measurement.
    limitations: >-
      A complete knockout models null activity, whereas the human allele is a
      missense variant whose activity is altered rather than abolished, so the
      severity is not matched. The direction of the rate change is also opposite
      to that seen in cold-stressed yeast, so this model fixes the fidelity claim
      but not a direction of translational rate change.
    evidence:
    - reference: PMID:27065197
      reference_title: Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Deletion of mtEF4 accelerated mitochondrial translation at the cost of producing unstable proteins."
      explanation: >-
        Supports treating the knockout mouse as informative for the
        translation-fidelity node.
  - target: Neuronal Energy Failure and Epileptic Encephalopathy
    relationship: FAILS_TO_RECAPITULATE
    fidelity: LOW
    model_scale: ORGANISM
    description: >-
      The mouse knockout does not reproduce the human neurological endpoint. The
      reported consequence of mtEF4 ablation is testis-specific oxidative
      phosphorylation dysfunction causing male infertility; somatic tissues,
      which include the brain, compensate by upregulating mTOR-driven cytoplasmic
      translation to match the accelerated mitochondrial rate.
    limitations: >-
      This is a reported absence of a neurological phenotype in a study designed
      around fertility, not a dedicated neurological or EEG assessment, so it is
      weaker than a deliberate negative finding. The compensation mechanism was
      characterised in somatic tissue generally rather than in neurons
      specifically, and mouse and human may differ in the developmental window
      over which such compensation is available.
    evidence:
    - reference: PMID:27065197
      reference_title: Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis.
      supports: REFUTE
      evidence_source: MODEL_ORGANISM
      snippet: "Here we report that genetic ablation of mitochondrial EF4 (mtEF4) in mice causes testis-specific dysfunction in oxidative phosphorylation, leading to male infertility."
      explanation: >-
        The phenotype of mtEF4 ablation in the mouse is testis-specific and does
        not include the encephalopathy this node models, which refutes the mouse
        as a model of the human neurological endpoint.
    - reference: PMID:27065197
      reference_title: Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Somatic tissues overcame this defect by activating mechanistic (mammalian) target of rapamycin (mTOR), thereby increasing rates of cytoplasmic translation to match rates of mitochondrial translation."
      explanation: >-
        Gives the mechanism by which somatic tissues escape the defect, which is
        the proposed explanation for why the mouse spares the nervous system.
- name: mtef4-null Caenorhabditis elegans
  species: Caenorhabditis elegans
  genotype: mtef4 (C. elegans mtEF4 ortholog) deletion
  category: Genetic
  publication: PMID:24837196
  description: >-
    Deleting the C. elegans mtEF4 ortholog produces mitochondrial dysfunction,
    growth delay and reduced brood size at normal temperature, and at low
    temperature reduces mitochondrial translation and disrupts complex
    IV-containing respiratory chain supercomplexes. It is the model that connects
    the translation defect to respiratory chain assembly in a whole metazoan.
  modeled_mechanisms:
  - target: Defective Respiratory Chain Complex Assembly
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: ORGANISM
    description: >-
      Loss of mtEF4 in the worm disrupts assembly of respiratory chain
      supercomplexes containing complex IV, the assembly failure this node
      models.
    limitations: >-
      The supercomplex disruption is observed at 15°C rather than at the animal's
      optimal temperature, so it is a cold-stress phenotype and may overstate what
      happens at mammalian body temperature. C. elegans has no nervous system
      comparable to the developing human cortex, so the model speaks to the
      assembly node only and not to the neurological consequence.
    evidence:
    - reference: PMID:24837196
      reference_title: Mitochondrial EF4 links respiratory dysfunction and cytoplasmic translation in Caenorhabditis elegans.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "At low temperature (15°C), mtef4 deletion reduces mitochondrial translation and disrupts the assembly of respiratory chain supercomplexes containing complex IV."
      explanation: >-
        Supports treating the worm deletion as informative for the respiratory
        chain assembly node.
  evidence:
  - reference: PMID:24837196
    reference_title: Mitochondrial EF4 links respiratory dysfunction and cytoplasmic translation in Caenorhabditis elegans.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "At worms' optimum growing temperature (20°C), mtef4 deletion leads to self-brood size reduction, growth delay and mitochondrial dysfunction."
    explanation: >-
      Establishes that the deletion causes mitochondrial dysfunction in this
      organism even without cold stress.
experimental_models:
- name: Yeast guf1-null complementation assay
  description: >-
    Saccharomyces cerevisiae lacking GUF1 has cold- and heat-sensitive growth
    defects on non-fermentable carbon sources and defective cytochrome oxidase
    assembly. Complementing that strain with human GUF1 alleles grades their
    function, and this is the assay that supplied the only functional evidence for
    the patient variant.
  experimental_model_type: OTHER
  organism:
    preferred_term: Saccharomyces cerevisiae
    term:
      id: NCBITaxon:4932
      label: Saccharomyces cerevisiae
  publication: PMID:26486472
  modeled_mechanisms:
  - target: Impaired Mitochondrial Translation Elongation Fidelity
    relationship: MEASURES
    fidelity: MODERATE
    model_scale: CELLULAR
    description: >-
      The complementation assay reads out how well a given GUF1 allele supports
      mitochondrial protein synthesis under the suboptimal conditions in which
      the factor is required, which is the functional grading behind the
      pathogenicity claim.
    limitations: >-
      A yeast growth readout is several steps removed from a human neuronal
      phenotype, and the reported effect is a modification of activity under
      suboptimal conditions rather than a clear-cut loss, so the assay
      establishes that the variant is functionally consequential without
      quantifying how consequential it is for human brain development.
    evidence:
    - reference: PMID:26486472
      reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Yeast complementation assays show that the activity of GUF1(A609S) is modified in suboptimal environments."
      explanation: >-
        The assay result grading the patient allele, which is the measurement
        this model contributes.
  evidence:
  - reference: PMID:18442968
    reference_title: The membrane-bound GTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Mutants lacking Guf1 show cold- and heat-sensitive growth defects on non-fermentable carbon sources that are especially pronounced under nutrient-limiting conditions."
    explanation: >-
      Characterises the yeast null phenotype that makes the complementation
      readout interpretable.
discussions:
- discussion_id: gap_human_neuronal_bioenergetics
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Do DEE40 patients actually have a measurable respiratory chain or
    bioenergetic deficit, and is it present in neural tissue?
  attaches_to:
  - "pathophysiology#Defective Respiratory Chain Complex Assembly"
  - "pathophysiology#Neuronal Energy Failure and Epileptic Encephalopathy"
  rationale: >-
    Every respiratory chain observation supporting this entry comes from yeast,
    worm, or cultured human cancer cells. No muscle or fibroblast respiratory
    chain enzymology, lactate, or oxidative phosphorylation measurement has been
    published for a GUF1 patient, and the discovering authors present the link to
    West syndrome as a suggestion. Until such a measurement exists, the central
    effector node of this entry is supported only by cross-species inference,
    which is also why no conformance to a mitochondrial mechanism module is
    declared (see notes).
  proposed_experiments:
  - experiment_id: exp_guf1_patient_respiratory_chain
    name: Respiratory chain assessment in GUF1 patient-derived cells
    description: >-
      Measure respiratory chain complex activities, assembly by blue-native
      electrophoresis, and mitochondrial translation rates in fibroblasts or
      iPSC-derived neurons from a GUF1 p.(Ala609Ser) homozygote against controls,
      to establish whether the assembly defect seen in model systems is present
      in patient cells and whether it is neuron-selective.
  evidence:
  - reference: PMID:26486472
    reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "We suggest a new link between improper assembly of respiratory chain complexes and WS."
    explanation: >-
      The authors' own framing of the mechanism as a suggestion is what this gap
      records. Classified INDIRECT because it evidences the state of the argument
      rather than a measurement.
- discussion_id: gap_mouse_spares_nervous_system
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >-
    Why does mtEF4 knockout in the mouse produce testis-restricted disease while
    the human variant produces an epileptic encephalopathy with no reported
    fertility phenotype?
  attaches_to:
  - "pathophysiology#Neuronal Energy Failure and Epileptic Encephalopathy"
  - "animal_models#mtEF4 knockout mouse"
  rationale: >-
    This is a mismatch rather than an absence of evidence: the mouse knockout was
    made and characterised, and its phenotype is male infertility from
    testis-specific oxidative phosphorylation failure, with somatic tissues
    compensating through mTOR-driven cytoplasmic translation. The organ affected
    in the mouse is not the organ affected in the reported human family. Either
    the developing human brain cannot mount the somatic compensation that mouse
    somatic tissues can, or the human missense allele acts differently from a
    null, or the mouse neurological phenotype was simply not looked for. The
    distinction matters because the mouse is currently the only mammalian in vivo
    system available for this gene, and reading it as a model of DEE40 would
    misstate what has been shown.
  proposed_experiments:
  - experiment_id: exp_neuro_phenotyping_mtef4_mouse
    name: Neurological phenotyping of mtEF4-deficient mice
    description: >-
      Perform EEG, seizure-susceptibility and developmental assessment in
      constitutive and neuron-specific mtEF4 knockout mice, and measure mTOR
      pathway activity and cytoplasmic translation rates in brain, to test
      whether the nervous system is genuinely spared or merely unexamined, and
      whether neuronal compensation differs from that in other somatic tissues.
  - experiment_id: exp_knockin_a609s_mouse
    name: Knock-in of the patient allele
    description: >-
      Generate a mouse carrying the orthologous p.(Ala609Ser) substitution rather
      than a null allele, to test whether the human missense variant produces a
      neurological phenotype that complete ablation does not.
  evidence:
  - reference: PMID:27065197
    reference_title: Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Here we report that genetic ablation of mitochondrial EF4 (mtEF4) in mice causes testis-specific dysfunction in oxidative phosphorylation, leading to male infertility."
    explanation: >-
      Documents the tissue specificity of the mouse phenotype, which is the
      mismatch with the human presentation that this discussion records.
notes: >-
  Scale of the evidence. This entry is deliberately shallow because the
  literature is. Human evidence for DEE40 consists of one consanguineous family
  with three affected siblings (PMID:26486472) and one further GUF1 patient
  counted in a targeted-panel cohort (PMID:37820178). Everything mechanistic
  comes from yeast, C. elegans, mouse, or cultured human cancer cells. Phenotypes
  are curated only where the cached source supports them: the accessible record
  for the primary paper carries the abstract and reference list but not the case
  narratives, so features that would be expected in an early infantile
  encephalopathy — microcephaly, hypotonia, specific neuroimaging findings — are
  deliberately absent rather than assumed. The three West syndrome triad
  phenotypes are marked directness INDIRECT because they follow from the stated
  syndrome diagnosis rather than from per-patient description.

  Deliberate non-conformances. No conforms_to is declared, and two candidate
  modules were considered and rejected. The mitochondrial_dysfunction module
  scopes itself to the aging hallmark and expects its central effector node to
  carry decreased oxidative phosphorylation and increased reactive oxygen species;
  neither has been measured in a GUF1 patient, and the ROS arm is stated as a
  possibility even in the mtEF4 review (PMID:30693836). The
  complex_iv_assembly_deficiency module models isolated cytochrome c oxidase
  deficiency as a human biochemical diagnosis, and no COX enzymology exists for
  any DEE40 patient; the complex IV signal here is entirely from yeast and worm.
  Declaring either conformance would assert measurements that have not been made
  (see gap_human_neuronal_bioenergetics). This should be revisited if patient
  respiratory chain data are published.

  No antiseizure treatment is curated. Neither human report describes the
  seizure response of a GUF1 patient to any specific drug. The 2023 cohort paper
  discusses antiseizure regimens in two places, and neither licenses a DEE40
  treatment entry. Its Dravet syndrome passage names agents for a different
  patient with a different gene, so attributing those to DEE40 would be
  named-entity confusion. Its West syndrome passage reports that the risk of
  developing Lennox-Gastaut syndrome was lower in patients who received a
  ketogenic diet, prednisone, or ACTH — but that is a cohort-level association
  in mixed-etiology West syndrome, made while recounting a 98-patient follow-up
  study, reported for LGS risk rather than for seizure response, and the paper
  never states that its GUF1 patient was among its four West syndrome patients.
  Curating those agents here would attribute a population-level
  infantile-spasms observation to a four-patient disease that no source
  connects them to. Only genetic counselling is curated, which the recessive
  consanguineous pedigree supports directly.

  Prevalence caveat. The 1:3500 live-birth figure in the primary report is the
  incidence of West syndrome from all causes and is recorded in the prevalence
  notes explicitly as not a DEE40 rate.
references:
- reference: PMID:26486472
  title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
- reference: PMID:37820178
  title: Importance of targeted next-generation sequencing in pediatric patients with developmental epileptic encephalopathy.
- reference: PMID:18442968
  title: The membrane-bound GTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions.
- reference: PMID:27065197
  title: Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis.
- reference: PMID:24837196
  title: Mitochondrial EF4 links respiratory dysfunction and cytoplasmic translation in Caenorhabditis elegans.
- reference: PMID:29572227
  title: Human Elongation Factor 4 Regulates Cancer Bioenergetics by Acting as a Mitochondrial Translation Switch.
- reference: PMID:30693836
  title: Mitochondrial translation factor EF4 regulates oxidative phosphorylation complexes and the production of ROS.
- reference: ORPHA:697160
  title: Infantile epileptic spasms syndrome
📚

References & Deep Research

References

8
West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
No top-level findings curated for this source.
Importance of targeted next-generation sequencing in pediatric patients with developmental epileptic encephalopathy.
No top-level findings curated for this source.
The membrane-bound GTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions.
No top-level findings curated for this source.
Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis.
No top-level findings curated for this source.
Mitochondrial EF4 links respiratory dysfunction and cytoplasmic translation in Caenorhabditis elegans.
No top-level findings curated for this source.
Human Elongation Factor 4 Regulates Cancer Bioenergetics by Acting as a Mitochondrial Translation Switch.
No top-level findings curated for this source.
Mitochondrial translation factor EF4 regulates oxidative phosphorylation complexes and the production of ROS.
No top-level findings curated for this source.
Infantile epileptic spasms syndrome
No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Create: developmental and epileptic encephalopathy, 40 · 2026-09-06T00:34:23Z · View source

De novo curation of DEE40 (MONDO:0014895), the first GUF1 (hgnc:25799) entry in the KB and a mitochondrial-translation DEE distinct from the ion-channel DEEs. Claim issue 11070. Deep research: falcon (Edison) was requested but returned HTTP 402 (account out of credits) on every attempt; the run used the repository fallback mechanism (just dr_fallback='--fallback') and was produced by claude_code, with fell_back/requested_provider/provider_attempts stamped in the report frontmatter. Report reference validation: 13/13 identifiers verified, 14/14 quotes valid; preflight-dr PASS against MONDO:0014895 (GUF1=58 mentions, OMIM 617065 matches; mondo_id passed manually per issue 10335). Entry: 4-node pathophysiology chain (biallelic GUF1 variants -> impaired mitochondrial translation elongation fidelity -> defective respiratory chain complex assembly -> neuronal energy failure/epileptic encephalopathy), 5 HP-bound phenotypes, AR inheritance bound to HP:0000007, GUF1 genetic block with p.(Ala609Ser) variant detail, CASES_IN_LITERATURE prevalence (4 reported patients), mtEF4 knockout mouse (FAILS_TO_RECAPITULATE the neurological endpoint, substantiated), yeast and C. elegans experimental models, one KNOWLEDGE_GAP and one HUMAN_MODEL_MISMATCH discussion. Phenotypes reported only in OMIM's synopsis or the primary paper's full text (hypotonia, spasticity, absent speech, microcephaly) were deliberately omitted because the cached record carries only the abstract and no exact quote can be validated; recorded in entry notes. No conforms_to declared: mitochondrial_dysfunction (aging-hallmark scope) and complex_iv_assembly_deficiency (requires human COX enzymology, none exists for GUF1 patients) were considered and rejected, reasoning in entry notes. No antiseizure pharmacotherapy curated: neither human report documents a drug response in a GUF1 patient; the 2023 cohort's regimen prose concerns its Dravet patient (named-entity confusion risk). Validation: just validate, validate-terms, count-verified-snippets (35/35), check-folded-hyphens, check-snippet-length, check-title-snippets, check-snippet-grading, check-duplicate-keys, check-entity-refs, check-causal-targets, check-qualifier-terms, check-enum-values, and the authoritative validate-disorders all PASS. Branch fast-forwarded to origin/main before final validation to clear stale-base title-snippet noise from IgG4-Related_Disease.

Claude Code ▸
1. Disease Information
claude-fable-5[1m], claude-haiku-4-5-20251001 18 citations 2026-09-05T18:29:24.003510

1. Disease Information

Overview. Developmental and epileptic encephalopathy 40 (DEE40) is an ultra-rare autosomal recessive mitochondrial-translation disorder caused by biallelic variants in GUF1 (GTP-binding elongation factor GUF1, chromosome 4p12). It presents as West syndrome: refractory infantile spasms beginning in the first 6 months of life with hypsarrhythmia on EEG, followed by developmental stagnation/regression and severe, lifelong neurologic impairment. It is the only human disease so far attributed to GUF1, the human homolog of bacterial elongation factor 4 (EF4/LepA), a quality-control back-translocase of the mitochondrial ribosome. The disease was delineated by Alfaiz et al. (2016) in three affected siblings of a consanguineous family (PMID:26486472).

Identifiers.

Resource Identifier
OMIM (phenotype) #617065 (DEE40; formerly EIEE40)
OMIM (gene) *617064 (GUF1)
MONDO MONDO:0014895 — "developmental and epileptic encephalopathy, 40" (verified in the local MONDO cache)
Gene GUF1, HGNC:25799 (hgnc:25799 in dismech convention), NCBI Gene 60558, chromosome 4p12
Orphanet No dedicated ORPHA code; Orphanet lists GUF1 as a disease-causing gene for Infantile spasms syndrome (ORPHA:3451)
ICD-10 / ICD-11 Category-level only: G40.4 (other generalized epilepsy and epileptic syndromes) / 8A62 (developmental and epileptic encephalopathies)
ClinVar (founder variant) RCV000239484 (GUF1 c.1825G>T, p.Ala609Ser)

Synonyms: EIEE40 (early infantile epileptic encephalopathy-40), GUF1-related epileptic encephalopathy, GUF1-related West syndrome.

Data provenance. All clinical information derives from aggregated disease-level resources (OMIM, Orphanet, PanelApp, GenCC) and case-level primary literature — principally one deeply phenotyped sibship (PMID:26486472) plus one additional GUF1-positive patient in a Turkish targeted-NGS cohort (PMID:37820178). No EHR-derived or registry data exist.

Gene-disease validity status (important caveat). The evidence base remains thin: Genomics England PanelApp rates GUF1 AMBER on the "Early onset or syndromic epilepsy" panel (panel 402), and GenCC classifications are "Limited"/"Supportive" (HGNC:25799). A diagnostic-grade (green) rating requires ≥3 unrelated families or 2 families plus convincing functional data; DEE40 currently rests on one family with functional support plus isolated panel-cohort hits.


2. Etiology

Primary cause. Homozygous missense variant in GUF1. In the index family, exome sequencing of a consanguineous family (reported by OMIM as of Algerian origin) with three affected siblings identified a homozygous c.1825G>T / p.(Ala609Ser) transversion in exon 15, segregating with disease. Direct quote (PMID:26486472):

"We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."

"The variant identified in the WS family changes an alanine residue conserved in all eukaryotic organisms and positioned within the tRNA-binding moiety of this nuclear genome-encoded mitochondrial translational elongation factor."

Risk factors. - Genetic: biallelic GUF1 variants; heterozygous carriers are unaffected (autosomal recessive). - Consanguinity is the dominant epidemiologic risk factor — the index family was consanguineous, and homozygosity for an ultra-rare allele is the expected mechanism of recurrence. - Environmental risk/protective factors: none identified; no gene-environment interaction data exist (CTD has no curated GUF1 disease-chemical interactions relevant to this phenotype). A biologically plausible but unproven consideration: GUF1/EF4 function is most critical under cellular stress (temperature, nutrient limitation, ionic stress) in all model systems (PMID:18442968; PMID:24837196), suggesting physiologic stressors could modulate expressivity — this is inference, not observation.

Protective factors. None reported (no protective variants, modifier alleles, or environmental factors documented).


3. Phenotypes

All frequencies below refer to the 3 reported sibs plus OMIM's clinical synopsis; treat "3/3" as the effective denominator.

Phenotype Type Onset Severity/Course Frequency Suggested HPO
Infantile spasms (epileptic spasms) Clinical sign < 6 months Refractory to treatment All reported HP:0012469 (Infantile spasms)
Hypsarrhythmia EEG/laboratory abnormality Infancy Pathognomonic of West syndrome All reported HP:0002521 (Hypsarrhythmia)
Developmental regression / stagnation Behavioral/developmental After seizure onset Severe, non-recovering All reported HP:0002376 (Developmental regression)
Profound intellectual disability Cognitive Established by childhood Profound All reported HP:0002187 (Profound intellectual disability)
Absent language Behavioral — Persistent All reported HP:0001344 (Absent speech)
Axial hypotonia Clinical sign Infancy — Reported HP:0008936 (Axial hypotonia)
Peripheral spasticity Clinical sign Infancy onward — Reported HP:0001257 (Spasticity)
Poor/limited eye contact Behavioral Infancy — Reported HP:0000817 (Reduced eye contact)
Poor feeding Symptom Infancy — Reported HP:0011968 (Feeding difficulties)
Poor fine motor skills Clinical sign Childhood — Reported HP:0007010 (Poor fine motor coordination)

Key phenotype description (OMIM #617065 clinical summary): DEE40 is "characterized by the onset of refractory infantile spasms within the first 6 months of life"; infants "may have normal or mildly delayed development before the onset of seizures, but thereafter show developmental stagnation and severe neurologic impairment"; EEG "typically shows hypsarrhythmia, consistent with a clinical diagnosis of West syndrome."

The defining West syndrome triad, quoted exactly from the index paper (PMID:26486472):

"West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."

Quality-of-life impact. No formal QoL instruments (EQ-5D, PedsQL) have been applied to DEE40. By analogy with cohort data on epileptic encephalopathies generally, dependency is severe: in the Turkish DEE cohort containing the fourth GUF1 patient, patients with severe intellectual disability were "completely dependent on the help of their relatives in their daily life activities" (PMID:37820178).


4. Genetic/Molecular Information

Causal gene. GUF1 (HGNC:25799; NCBI Gene 60558; OMIM 617064; 4p12). Encodes a nuclear-encoded, mitochondrially targeted translation elongation factor — the human ortholog of E. coli LepA/EF4 and S. cerevisiae* Guf1. UniProt: GUF1_HUMAN (Q8N442).

Pathogenic variants. - c.1825G>T, p.(Ala609Ser) — exon 15, homozygous, germline; missense; the sole published segregating allele (PMID:26486472). ClinVar RCV000239484. Ala609 is "conserved in all eukaryotic organisms and positioned within the tRNA-binding moiety" of the protein (PMID:26486472). Functional class: neither clean loss nor gain — a conditional/context-dependent hypomorph; yeast complementation showed "the activity of GUF1(A609S) is modified in suboptimal environments" (PMID:26486472). - One additional GUF1-mutated patient was identified by a 54-gene targeted epilepsy panel in a Turkish DEE cohort (1 GUF1 hit among 48 genetically solved of 198 patients; variant details not given in the paper) (PMID:37820178). - Allele frequency: the A609S allele is absent/ultra-rare in population databases (per the original report); no recurrent or founder alleles are otherwise documented in gnomAD at appreciable frequency. - All variants reported to date are germline; there is no somatic disease association for this phenotype (mtEF4 overexpression has a separate somatic-cancer literature — see §6).

Modifier genes, epigenetics, chromosomal abnormalities. None identified. No DNA-methylation or chromatin data specific to DEE40 exist; no structural variants of GUF1 have been reported as causal.


5. Environmental Information

No environmental, lifestyle, or infectious contributors are documented for DEE40; it is a fully penetrant (within the one reported family) Mendelian mitochondrial disorder. The only environment-adjacent observation is mechanistic: GUF1/EF4 function becomes rate-limiting under stress conditions (low temperature, nutrient limitation, altered Mg²⁺) in yeast, worm, and bacterial systems — see §6.


6. Mechanism / Pathophysiology

Causal chain (ordered)

  1. Biallelic GUF1 missense variant (p.Ala609Ser in the tRNA-binding domain) leads to altered activity of the mitochondrial elongation factor 4 (mtEF4/GUF1), demonstrated in yeast complementation under suboptimal conditions (PMID:26486472). (demonstrated, model system)
  2. Impaired GUF1 back-translocase activity results in loss of quality control over mitochondrial translation elongation — failure to remobilize stalled mitoribosomes and to pace elongation (PMID:18442968; PMID:26486472). (demonstrated in yeast/bacteria; inferred for human)
  3. Dysregulated mitochondrial translation results in synthesis of unstable/misassembled mtDNA-encoded OXPHOS subunits (PMID:27065197: "Deletion of mtEF4 accelerated mitochondrial translation at the cost of producing unstable proteins"). (demonstrated, mouse)
  4. Misassembly leads to defective respiratory-chain complex biogenesis, with complex IV (cytochrome c oxidase) assembly most affected (yeast: "defects in the assembly of cytochrome oxidase," PMID:18442968; C. elegans: "disrupts the assembly of respiratory chain supercomplexes containing complex IV," PMID:24837196). (demonstrated, model systems)
  5. Respiratory-chain dysfunction results in deficient oxidative phosphorylation, plus increased electron leakage and ROS production (PMID:30693836; PMID:29572227: "Knockout of mtEF4 induced respiratory chain complex defects and apoptosis"). (demonstrated in vitro/model; inferred in patients)
  6. Bioenergetic failure in the developing brain leads to cortical network dysfunction and hyperexcitability, manifesting as infantile spasms with hypsarrhythmia. (inferred — this is the step the index paper frames as a hypothesis: "We suggest a new link between improper assembly of respiratory chain complexes and WS," PMID:26486472; it is consistent with the broader literature placing mitochondrial/respiratory-chain disease among infantile-spasm etiologies)
  7. Ongoing epileptic activity plus chronic neuronal energy deficit result in developmental stagnation/regression and profound intellectual disability — the "developmental and epileptic" encephalopathy. (inferred; conforms to the ILAE epileptic-encephalopathy concept)

Branch (tissue-specificity / compensation). In mouse, somatic tissues buffer mtEF4 loss: "Somatic tissues overcame this defect by activating mechanistic (mammalian) target of rapamycin (mTOR), thereby increasing rates of cytoplasmic translation to match rates of mitochondrial translation," whereas cells that developmentally downregulate mTOR (spermatogenic cells) undergo "cell-cycle arrest and apoptosis" (PMID:27065197). Why the human brain is vulnerable while the mouse brain is spared is an open question — plausibly the human A609S allele behaves differently from a null, and/or neuronal mTOR-mediated compensation is insufficient in the developing human cortex. This is an explicit human-model mismatch (see §15).

Supporting detail by category

  • Molecular pathways: mitochondrial translation elongation and its quality control (GO:0070125 mitochondrial translational elongation; GO:0032543 mitochondrial translation); ribosomal back-translocation — "it is able to remobilize stuck ribosomes and transiently inhibit the elongation process to optimize protein synthesis" (PMID:26486472); mTOR-mediated mito-cytoplasmic translational cross-talk (PMID:27065197); oxidative phosphorylation (GO:0006119).
  • Protein dysfunction: GUF1 is a ribosome-dependent GTPase (GO:0003924) "located in the mitochondrial matrix and tightly associated with the inner membrane," binding "mitochondrial ribosomes in a GTP-dependent manner" (yeast, PMID:18442968). A609S perturbs the tRNA-binding module rather than abolishing the protein.
  • Cellular processes: mitoribosome rescue/fidelity; respiratory-complex assembly (GO:0033617 mitochondrial respiratory chain complex IV assembly); apoptosis upon severe OXPHOS failure (PMID:29572227).
  • Metabolic changes: OXPHOS deficiency; predicted redox imbalance — mtEF4 loss "could result in cytochrome c peroxidase formation, electron leakage from electron transport chain and ROS increase" (PMID:30693836).
  • Immune involvement: none.
  • Cell types / anatomy: cortical neurons (CL:0000540 neuron; CL:0010012 cerebral cortex neuron) are the presumed vulnerable population, given the purely neurologic phenotype; no patient tissue studies exist.
  • Molecular profiling: none in patients. In C. elegans, mtef4 deletion "induces retrograde pathways, including mitochondrial biogenesis and cytoplasmic translation reorganization" by transcriptomics (PMID:24837196). Human tissue survey: "EF4 was ubiquitous in human tissues with localization to the mitochondria (mtEF4) and performed quality control on respiratory chain biogenesis" (PMID:29572227).
  • Evidence-source classification: the chain above rests on IN_VITRO (yeast complementation, human cell lines), MODEL_ORGANISM (mouse, C. elegans), and HUMAN_CLINICAL genetics (segregation in one family); no direct human biochemical confirmation (e.g., muscle respiratory-chain enzymology in a patient) has been published — a genuine knowledge gap worth recording.

7. Anatomical Structures Affected

  • Organ level: brain (UBERON:0000955), specifically cerebral cortex (UBERON:0000956) as the seat of hypsarrhythmia/spasms; nervous system exclusively — no cardiac, hepatic, renal, or ophthalmologic involvement reported.
  • Tissue/cell level: neurons (CL:0000540); no neuropathology has been published.
  • Subcellular level: mitochondrion (GO:0005739); mitochondrial matrix (GO:0005759); mitochondrial inner membrane (GO:0005743); mitochondrial ribosome (GO:0005761).
  • Lateralization: hypsarrhythmia and spasms are generalized/bilateral.

8. Temporal Development

  • Onset: infantile — refractory spasms within the first 6 months of life (OMIM); development before onset normal or mildly delayed.
  • Progression: epileptic-encephalopathy pattern — seizure onset is followed by developmental stagnation and regression; thereafter the course is one of static severe impairment (profound ID, absent language) rather than documented ongoing neurodegeneration. Seizures are refractory.
  • Course pattern: chronic, lifelong; no remissions reported.
  • Critical period: infancy — as for all infantile-spasm syndromes, the window for hormonal/vigabatrin therapy is early; whether prompt treatment alters outcome in DEE40 specifically is unknown (spasms were refractory in the reported family).

9. Inheritance and Population

  • Inheritance: autosomal recessive (HP:0000007). Homozygosity in a consanguineous family; parents unaffected carriers.
  • Penetrance/expressivity: apparently complete penetrance and consistent expressivity within the single sibship (3/3 affected homozygotes); no inter-familial comparison possible.
  • Anticipation, germline mosaicism, founder effects: none reported; A609S may represent a private allele.
  • Consanguinity: central — the index family was consanguineous; expect DEE40 predominantly in populations with elevated autozygosity.
  • Carrier frequency: unknown; presumably extremely low.
  • Epidemiology: ultra-rare — 4 reported patients worldwide (3 sibs, PMID:26486472; 1 Turkish panel case, PMID:37820178). For context, West syndrome of all causes affects "about 1:3500 live births" (PMID:26486472). Sex ratio in reported cases includes both sexes (the index sibship included male and female children). Suggested dismech prevalence class: CASES_IN_LITERATURE.

10. Diagnostics

  • Electrophysiology: EEG is the pivotal test — hypsarrhythmia (interictal) with epileptic spasms; evolution should be followed as West syndrome can transform to other encephalopathy patterns (Lennox-Gastaut evolution is seen in 20–48% of West syndrome generally, PMID:37820178).
  • Imaging: brain MRI to exclude structural etiologies; in the DEE cohort containing a GUF1 patient, "There was no structural anomaly that could cause a seizure" (PMID:37820178). No DEE40-specific imaging signature is established.
  • Laboratory/biochemical: standard metabolic screening is typically unrevealing ("Metabolic examination tests were performed in all patients, and no specific findings indicative of a disease were detected," PMID:37820178). Respiratory-chain enzymology (muscle/fibroblast) is mechanistically rational (predicted complex IV assembly defect) but has not been reported in a patient.
  • Genetic testing (the diagnostic mainstay):
  • Exome/genome sequencing — how the index family was solved ("we exome-sequenced the members of a consanguineous family affected with isolated WS," PMID:26486472).
  • Targeted NGS epilepsy panels — GUF1 is included on commercial and academic EIEE/DEE panels (e.g., the 54-gene Turkish panel, PMID:37820178; GTR lists GUF1 clinical tests under Gene 60558). Trio testing to confirm segregation and biallelic phase.
  • CMA/karyotype/FISH/mtDNA/repeat testing: not informative for GUF1 point variants (though mtDNA testing belongs in the differential workup of mitochondrial epilepsy).
  • Variant interpretation caution: given PanelApp AMBER / GenCC Limited status, a novel biallelic GUF1 variant in a DEE patient should be reported conservatively (often VUS-to-likely-pathogenic territory) unless functional or segregation data are strong.
  • Differential diagnosis: the full West-syndrome gene spectrum (CDKL5, ARX, STXBP1, KCNQ2, TBC1D24, SLC25A22, etc.) and mitochondrial epilepsies (mtDNA mutations such as m.8993T>G, nuclear mitochondrial-translation defects — e.g., TSFM, RARS2); tuberous sclerosis and structural/metabolic causes must be excluded per ILAE criteria.
  • Screening: not part of newborn screening; carrier/cascade testing appropriate within an affected family.

11. Outcome / Prognosis

  • Survival: no mortality data; the reported sibs survived infancy. Life expectancy unquantified.
  • Morbidity: severe — profound intellectual disability, absent language, motor impairment (axial hypotonia + peripheral spasticity, poor fine motor skills), refractory epilepsy; full dependency for activities of daily living is expected from the DEE literature (PMID:37820178).
  • Prognostic factors: none established within DEE40 (n too small). Extrapolating from West syndrome generally, etiology and treatment latency drive outcome; genetically determined ("symptomatic") West syndrome carries the poorer developmental prognosis, and DEE40's reported course fits that pattern.
  • Complications: evolution toward other epileptic encephalopathy patterns (LGS risk after infantile spasms is 20–48% in general cohorts, PMID:37820178); feeding difficulties with attendant nutritional risk.
  • Recovery potential: none demonstrated; developmental stagnation persisted despite management in the reported family.

12. Treatment

There is no disease-specific or mechanism-directed therapy. Management follows standard-of-care for infantile spasms/West syndrome and supportive care for severe DEE.

Intervention Notes Suggested NCIT
Hormonal therapy (ACTH, high-dose oral corticosteroids) First-line for infantile spasms per consensus (US consensus report; UKISS) NCIT:C15986 Pharmacotherapy (+ agent terms)
Vigabatrin First-line alternative (first choice in TSC; used broadly in spasms) NCIT:C15986 Pharmacotherapy; agent CHEBI:63638 (vigabatrin)
Antiseizure medications (valproate, benzodiazepines, topiramate, levetiracetam, etc.) Seizures reported refractory in DEE40 NCIT:C15986 Pharmacotherapy
Ketogenic diet Used in refractory spasms; in one cohort, ketogenic diet/prednisone/ACTH exposure was associated with lower LGS evolution risk (PMID:37820178) NCIT:C15447 Dietary Intervention
Supportive/rehabilitative care: physiotherapy, feeding support, spasticity management Standard for profound DEE NCIT:C15747 Supportive Care; NCIT:C15302 Physical Therapy
Genetic counseling for the family AR recurrence risk 25% NCIT:C15240 Genetic Counseling
  • Pharmacogenomics: none specific to GUF1.
  • Advanced therapeutics: no gene therapy, ASO, or clinical trial (no NCT identifiers) targets GUF1/DEE40. A speculative mechanistic lead — mTOR-pathway modulation of the mitochondrial/cytoplasmic translation balance (PMID:27065197) — has not been tested therapeutically and cuts both ways (compensation in mouse required mTOR activation).
  • Treatment response: the defining feature is refractoriness of the spasms; no DEE40-specific response rates exist.

13. Prevention

  • Primary prevention: none for the disorder itself; genetic counseling in consanguineous families is the actionable lever.
  • Secondary prevention: early recognition of spasms and prompt EEG — critical for all infantile-spasm syndromes; rapid genetic diagnosis (panel/exome) ends the diagnostic odyssey and informs counseling ("Understanding the genetic etiology is vital for genetic counseling and, maybe, the future development of remedies for the etiology," PMID:37820178).
  • Tertiary prevention: aggressive seizure management to limit encephalopathic impact; standard DEE complication surveillance (nutrition, orthopedic sequelae of spasticity).
  • Reproductive options: carrier testing of relatives, prenatal diagnosis, and PGT are technically feasible once the familial variants are known.
  • Vaccination, public-health, and behavioral prevention: not applicable.

14. Other Species / Natural Disease

No naturally occurring GUF1-deficiency disease is documented in companion animals or wildlife (no OMIA entry). The gene is, however, among the most anciently conserved translation factors, and the comparative biology is unusually rich:

  • E. coli LepA/EF4: the founding member; "the bacterial elongation factor LepA was identified as critical for the accuracy of in vitro translation reactions" (PMID:18442968); structural and single-molecule work established back-translocation (Qin et al., Cell 2006; Evans et al., PNAS 2008; Liu et al., PNAS 2011). In vivo, LepA contributes to tellurite resistance and is required for H. pylori growth in acid — fitness under stress, not viability.
  • S. cerevisiae Guf1: mitochondrial matrix GTPase; deletion causes "cold- and heat-sensitive growth defects on non-fermentable carbon sources… especially pronounced under nutrient-limiting conditions" and "defects in the assembly of cytochrome oxidase," with synthetic sickness with oxa1 insertase mutants (PMID:18442968). This is the system used to functionally test the patient allele (PMID:26486472).
  • C. elegans mtEF4: "mtef4 deletion leads to self-brood size reduction, growth delay and mitochondrial dysfunction," and at 15 °C "reduces mitochondrial translation and disrupts the assembly of respiratory chain supercomplexes containing complex IV" (PMID:24837196).
  • Mouse Guf1/mtEF4: knockout "causes testis-specific dysfunction in oxidative phosphorylation, leading to male infertility" (PMID:27065197); a prior report similarly found loss of Guf1 impairs sperm mitochondrial function (Piao & Jin, Biol Reprod 2015). NCBI Taxon suggestions: NCBITaxon:9606 (human), NCBITaxon:10090 (mouse), NCBITaxon:6239 (C. elegans), NCBITaxon:4932 (S. cerevisiae), NCBITaxon:562 (E. coli).
  • Evolutionary note: EF4 has long been called a paradox — "highly conserved, yet of no physiological significance?" (Zhang & Qin, Biochem J 2013) — because deletions across taxa lack overt phenotypes under optimal conditions; DEE40 supplies the missing organismal significance in humans.

15. Model Organisms

Model Type Recapitulation of DEE40 Key limitation
Yeast guf1Δ + GUF1(A609S) complementation In vitro / unicellular Variant-level functional model: "the activity of GUF1(A609S) is modified in suboptimal environments" (PMID:26486472) No nervous system; phenotype only under stress conditions
Mouse Guf1/mtEF4 KO (global and germline-specific) Mammalian knockout Fails to recapitulate the human neurologic disease — phenotype confined to spermatogenesis/male infertility; brain and heart grossly normal (PMID:27065197) Somatic mTOR-mediated compensation masks neuro phenotype; null allele vs. human missense; classic candidate for a dismech FAILS_TO_RECAPITULATE/HUMAN_MODEL_MISMATCH annotation
C. elegans mtef4 deletion Invertebrate Partial mechanism-level recapitulation: complex IV supercomplex assembly defect, temperature-dependent (PMID:24837196) No seizure/encephalopathy correlate; strongest at 15 °C
Human cell-line mtEF4 KO/knockdown In vitro Mechanism-level: "Knockout of mtEF4 induced respiratory chain complex defects and apoptosis" (PMID:29572227) Cancer-line context; not neuronal

Resources: MGI (Guf1), WormBase, SGD (GUF1/YLR289W), IMPC. Applications: the yeast complementation assay is the established readout for classifying new GUF1 missense variants — directly relevant to resolving future VUS. Unmet model need: no neuronal or brain-conditional model (e.g., patient iPSC-derived neurons, knock-in A609S mouse) exists; this is the experiment that would close the largest gap in the causal chain (step 6, §6).


Key open questions / knowledge gaps (for KB curation)

  1. Single-family gene-disease association (PanelApp AMBER, GenCC Limited) — additional unrelated biallelic families with phenotype detail are the rate-limiting evidence.
  2. No patient-level biochemical confirmation of respiratory-chain (complex IV) deficiency in any DEE40 patient tissue — the central mechanistic step is model-inferred.
  3. Human-model mismatch: mouse null has no neuro phenotype; mechanism of human brain vulnerability (allele behavior vs. compensation capacity) is unresolved.
  4. No natural-history, imaging, or treatment-response data beyond the index sibship.

Sources: - OMIM #617065 — Developmental and Epileptic Encephalopathy 40 - OMIM *617064 — GTP-Binding Elongation Factor GUF1 - Alfaiz et al. 2016, Eur J Hum Genet — West syndrome caused by homozygous GUF1 variant (PMID:26486472) - PMC version of Alfaiz et al. 2016 - Bauerschmitt et al. 2008, J Biol Chem — yeast Guf1 promotes mitochondrial protein synthesis under suboptimal conditions (PMID:18442968) - Gao et al. 2016, Nat Struct Mol Biol — mtEF4 knockout mouse, spermatogenesis (PMID:27065197) - Yang et al. 2014, BBA — C. elegans mtEF4 and respiratory dysfunction (PMID:24837196) - Zhu et al. 2018, Cancer Res — human EF4 as mitochondrial translation switch (PMID:29572227) - Li & Qin 2018, Free Radic Res — mtEF4, OXPHOS complexes and ROS (PMID:30693836) - Bariş et al. 2023, Rev Assoc Med Bras — targeted NGS in pediatric DEE, incl. 1 GUF1 patient (PMID:37820178) - Genomics England PanelApp — GUF1, Early onset or syndromic epilepsy panel (AMBER) - Genomics England PanelApp — GUF1, Mitochondrial disorders panel - GenCC — GUF1 (HGNC:25799) classifications - ClinGen — GUF1 curation results - NIH Genetic Testing Registry — GUF1 (Gene 60558) - Orphanet — GUF1 gene page (Infantile spasms syndrome, ORPHA:3451) - MalaCards — Developmental and Epileptic Encephalopathy 40 - GeneCards — GUF1

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome Count
References checked 13
Resolved 13
Unresolved (possible confabulation) 0
Unverifiable 0
Quoted claims checked 14
Quoted claims found in source 14
Quoted claims not found in source 0
References weighed for topical relevance 13
On topic 4
Off topic 0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 38
Resolved 36
Unresolved (possible confabulation) 0
Obsolete 0
Unverifiable 2
Terms whose name was checked 20
Terms named correctly 14
Terms named as a different term 2
Terms whose name is worth a second look 4

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

  • GO:0003924 (1 mention) - the report calls it "Protein dysfunction: GUF1 is a ribosome-dependent GTPase"; GO calls it GTPase activity**
  • CL:0000540 (2 mentions) - the report calls it "Tissue/cell level: neurons"; CL calls it neuron**

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

  • UBERON:0000955 (1 mention) - the report calls it "Organ level: brain"; UBERON calls it brain**, and lists "the brain" among its other names
  • GO:0005739 (1 mention) - the report calls it "Subcellular level: mitochondrion"; GO calls it mitochondrion**
  • NCBITaxon:6239 (1 mention) - the report calls it "C. elegans"; NCBITaxon calls it Caenorhabditis elegans, and lists "Rhabditis elegans" among its other names
  • NCBITaxon:4932 (1 mention) - the report calls it "S. cerevisiae"; NCBITaxon calls it Saccharomyces cerevisiae, and lists "Mycoderma cerevisiae" among its other names

Prefixes with no resolver

Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: ORPHA.